Is Gracell Biotechnologies Inc (GRCL) Stock at the Top of the Biotechnology Industry?

Monday, May 23, 2022 04:03 PM | InvestorsObserver Analysts

Mentioned in this article

Is Gracell Biotechnologies Inc (GRCL) Stock at the Top of the Biotechnology Industry?

Gracell Biotechnologies Inc (GRCL) is near the top in its industry group according to InvestorsObserver. GRCL gets an overall rating of 58. That means it scores higher than 58 percent of stocks. Gracell Biotechnologies Inc gets a 78 rank in the Biotechnology industry. Biotechnology is number 65 out of 148 industries.

GRCL has an Overall Score of 58. Find out what this means to you and get the rest of the rankings on GRCL!

See Full GRCL Report

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector. This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Gracell Biotechnologies Inc Stock Today?

Gracell Biotechnologies Inc (GRCL) stock is lower by -12.78% while the S&P 500 is up 1.86% as of 4:00 PM on Monday, May 23. GRCL has fallen -$0.45 from the previous closing price of $3.52 on volume of 99,627 shares. Over the past year the S&P 500 is down -5.32% while GRCL has fallen -83.33%. GRCL lost -$0.97 per share the over the last 12 months. Click Here to get the full Stock Report for Gracell Biotechnologies Inc stock.